Drug Type Monoclonal antibody |
Synonyms 2MW 3311, 2MW3311 |
Target |
Mechanism CXCR6 antagonists(C-X-C motif chemokine receptor 6 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | CN | 16 May 2024 |